Table 3

Race of participants in pembrolizumab trials by cancer site

SiteTrialsWhiteBlackAsianOtherAll
Ovary5118278135
Cervix21002128122
Uterus261341078
Breast1014271154511342127
All gynecologic 9 279 (83%) 7 (2%) 23 (7%) 26 (8%) 335
All sites191706 (69%)122 (5%)474 (19%)160 (6%)2462